Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer

NCT00365417 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Bevacizumab
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Capecitabine
DRUG: Docetaxel

Sponsor

NSABP Foundation Inc

Collaborators

[object Object]
[object Object]
[object Object]